Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2022 - Innovation
Download Issue
Share
Up Front
Publisher's Corner
Innovations for Improving Patient Treatment Outcomes
By Patrick M. Schmidt
Features
Update on Treatment Options for Alzheimer’s
By
Jim Trageser
Addressing the Healthcare Diversity Gap
By
Trudie Mitschang
Improving Patient Adherence Through Smart Packaging
By
Amy Scanlin, MS
Breakthroughs in Gene Therapy
By
Diane L.M. Cook
Pros and Cons of Virtual Care Solutions
By
Meredith Whitmore
Myths & Facts: Depression
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
HHS Awards $1.5 Billion Grant to Combat Opioid Addiction
HHS Launches the Inaugural PandemicX 2022 Cohort
NIH Establishes Antiviral Drug Discover Centers
HHS and ED Launch Joint-Department Effort to Expand School-Based Health Services
Reimbursement FAQs
Proposed Payment Systems and Fee Schedules in 2023
Healthcare Management
Telehealth: From Video Visits to Strategic Business
Industry News
NIAID Launches Study of Vaccine to Prevent EBV
IVIG May Reverse Symptoms of Down Syndrome Regression Disorder
Combination COVID-19 and Influenza Vaccine Under Development
Lyme Disease Vaccine Advances to Phase III Study
NIH Launches Study to Evaluate Three mRNA Vaccines for HIV
First Human Clinical Trial of Cancer Killing Virus Has Begun
Flu Vaccines Poor Match to Influenza Strains This Season
FDA Approves New Gene Therapy Treatment for Rare Blood Disorder
New Program Launched to Identify Autoimmune Disease Therapies
Intranasal Flu Vaccine Developed with Nanoparticles
New Test Detects and Measures Biomarkers in Blood Plasma to Earlier Diagnose Alzheimer’s
BioFocus
Industry Insight
Novel Immunotherapies Target RSV Disease at Both Ends of the Age Spectrum
By Keith Berman, MPH, MBA
Patient Profile
Depression: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Depression: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
IVIG Improves Live Birth Rate in Women with Immune Conditions and Recurrent Pregnancy Loss: Review and Meta-Analysis
Fitusiran Prophylaxis Reduces Bleeds Versus Prior Factor or Bypassing Agent Prophylaxis in Hemophilia A and B Patients